Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
https://www.zacks.com/stock/news/2286734/apellis-apls-up-on-upbeat-ga-data-from-long-term-syfovre-study?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2286734
Jun 11, 2024 - Apellis (APLS) rises 3.3% as the treatment of GA patients with Syfovre demonstrates a visual function benefit in a prespecified endpoint at month 36 in a late-stage, long-term extension study.
0
Where Will UPS Be in 3 Years?
https://www.fool.com/investing/2024/06/11/where-will-ups-be-in-3-years/?source=iedfolrf0000001
Jun 11, 2024 - The package delivery giant has laid out its medium-term goals. If it hits them, the stock at current prices will have been a great value opportunity.
0
Missed Out on Nvidia's Run-Up? My Best Artificial Intelligence (AI) Stock to Buy and Hold
https://www.fool.com/investing/2024/06/10/missed-out-on-nvidias-run-up-my-best-artificial-in/?source=iedfolrf0000001
Jun 10, 2024 - This semiconductor bellwether has played an important role in helping Nvidia dominate the AI chip market.
0
FTEC: Tech ETF Matches Up Well Against Bigger ETFs, But Risk/Reward An Issue Currently
https://seekingalpha.com/article/4698454-ftec-tech-etf-matches-up-well-against-bigger-etfs-but-riskreward-an-issue-currently?source=feed_tag_etf_portfolio_strategy
Jun 10, 2024 - The Fidelity Tech ETF measures up well against other tech ETFs, now may not be the right time to add any of them to your portfolio. Read more on FTEC here.
0
Can Tech ETFs Keep Up Their Winning Momentum?
https://www.zacks.com/stock/news/2286185/can-tech-etfs-keep-up-their-winning-momentum?cid=CS-ZC-FT-etf_news_and_commentary-2286185
Jun 10, 2024 - U.S. technology stocks recorded their largest weekly inflows last week in nine weeks. Can the winning momentum continue?
0
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
https://www.zacks.com/stock/news/2286219/geron-gern-wins-fda-approval-for-blood-cancer-drug-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2286219
Jun 10, 2024 - Geron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.
0
RH Gears Up to Report Q1 Earnings: Here's What to Expect
https://www.zacks.com/stock/news/2286121/rh-gears-up-to-report-q1-earnings-here-s-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2286121
Jun 10, 2024 - RH's fiscal first-quarter results are likely to reflect high mortgage rates, a soft luxury housing market and clearance pressure.
0
4 GARP Stocks to Scoop up for Maximum Returns
https://www.zacks.com/stock/news/2286096/4-garp-stocks-to-scoop-up-for-maximum-returns?cid=CS-ZC-FT-analyst_blog|rw-2286096
Jun 10, 2024 - Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RMD, BAH, BAP and AXP are some stocks that hold promise.
0
Cathie Wood Is Loading Up on UiPath Stock. Should You?
https://www.fool.com/investing/2024/06/10/cathie-wood-is-loading-up-on-uipath-stock-should-y/?source=iedfolrf0000001
Jun 10, 2024 - UiPath stock crashed following a downgraded profit outlook for 2024.
0
Dodgers can’t sweep Yankees as Tyler Glasnow gives up costly home run
https://www.ocregister.com/2024/06/09/dodgers-cant-sweep-yankees-as-tyler-glasnow-gives-up-costly-home-run/
Jun 09, 2024 - With Yankees fans chanting for injured Juan Soto, Trent Grisham hit a three-run home run off Glasnow to give the Yankees the lead.
0